These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 24335295)
21. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824 [TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. Sivakumar R; Sharma-Walia N; Raghu H; Veettil MV; Sadagopan S; Bottero V; Varga L; Levine R; Chandran B J Virol; 2008 Feb; 82(4):1759-76. PubMed ID: 18057235 [TBL] [Abstract][Full Text] [Related]
23. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers. Zhang YJ; Wang KY; Stein DA; Patel D; Watkins R; Moulton HM; Iversen PL; Matson DO Antiviral Res; 2007 Jan; 73(1):12-23. PubMed ID: 16842866 [TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells. Paudel N; Sadagopan S; Balasubramanian S; Chandran B J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534 [TBL] [Abstract][Full Text] [Related]
27. Regulation of KSHV Latency and Lytic Reactivation. Broussard G; Damania B Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532 [TBL] [Abstract][Full Text] [Related]
29. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396 [TBL] [Abstract][Full Text] [Related]
30. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M J Virol; 2017 May; 91(10):. PubMed ID: 28275189 [TBL] [Abstract][Full Text] [Related]
31. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. Wakeman BS; Izumiya Y; Speck SH J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414 [TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Lu C; Zeng Y; Huang Z; Huang L; Qian C; Tang G; Qin D Am J Pathol; 2005 Jan; 166(1):173-83. PubMed ID: 15632010 [TBL] [Abstract][Full Text] [Related]
33. Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen. George Paul A; Sharma-Walia N; Kerur N; White C; Chandran B Cancer Res; 2010 May; 70(9):3697-708. PubMed ID: 20388794 [TBL] [Abstract][Full Text] [Related]
34. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Fukumoto H; Kanno T; Hasegawa H; Katano H Front Microbiol; 2011; 2():175. PubMed ID: 21904536 [TBL] [Abstract][Full Text] [Related]
35. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection. Katano H Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675 [TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication. Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. Sun R; Tan X; Wang X; Wang X; Yang L; Robertson ES; Lan K PLoS Pathog; 2017 Jan; 13(1):e1006167. PubMed ID: 28118409 [TBL] [Abstract][Full Text] [Related]
39. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592 [TBL] [Abstract][Full Text] [Related]